The merit of tyrosine kinase inhibitors in the adjuvant setting of high-risk renal cell carcinoma: a meta-analysis

Hampig Raphael Kourie, Ziad Bakouny, Roland Eid, Fady GH Haddad, Joseph Kattan
  • Future Oncology, March 2018, Future Medicine
  • DOI: 10.2217/fon-2017-0333
The author haven't yet claimed this publicationThe author haven't yet claimed this publication

In partnership with: